{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T09:10:09Z","timestamp":1743671409349,"version":"3.40.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.bbrc.2012.06.136","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T20:02:10Z","timestamp":1341518530000},"page":"338-340","source":"Crossref","is-referenced-by-count":3,"title":["Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy"],"prefix":"10.1016","volume":"424","author":[{"given":"Shin-ichi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ikegaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.06.136_b0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1183\/09031936.00130209","article-title":"Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil","volume":"36","author":"Mouchaers","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2012.06.136_b0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1291\/hypres.25.491","article-title":"Inhibitory molecules in signal transduction pathways of cardiac hypertrophy","volume":"25","author":"Takano","year":"2002","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbrc.2012.06.136_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2012.06.136_b0020","first-page":"H1279","article-title":"Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho\/Rho-kinase, and PPARs in cardiomyocytes","volume":"295","author":"Doi","year":"2008","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","article-title":"A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage","volume":"68","author":"Suzuki","year":"2007","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","article-title":"Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo","volume":"93","author":"Higashi","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2012.06.136_b0035","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine","volume":"25","author":"Shimokawa","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/FJC.0b013e31816533b7","article-title":"Long-term inhibition of Rho-kinase ameliorates diastic heart failure in hypertensive rats","volume":"51","author":"Fukui","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0045","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0024-3205(01)01229-2","article-title":"Pharmacological profile of hydroxyl fasudil as a selective rho kinase inhibitor on ischemic brain damage","volume":"69","author":"Satoh","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2012.06.136_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainresbull.2009.08.021","article-title":"Amelioration of endothelial damage\/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage","volume":"81","author":"Satoh","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbrc.2012.06.136_b0055","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1161\/01.STR.0000181077.84981.11","article-title":"Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection","volume":"36","author":"Rikitake","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bbrc.2012.06.136_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1254\/jphs.11075FP","article-title":"Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage","volume":"118","author":"Satoh","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2012.06.136_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jjp.80.41","article-title":"Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction","volume":"80","author":"Satoh","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(02)02619-5","article-title":"Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction","volume":"455","author":"Satoh","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0075","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0022-2828(95)90042-X","article-title":"The effects of modulation of calcium influx through the voltage-sensitive calcium channel on cardiomyocyte hypertrophy","volume":"27","author":"Lubic","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-5347(25)00221-6","article-title":"Mechanism of action of a novel antivasospasm drug, HA1077","volume":"241","author":"Asano","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2012.06.136_b0085","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/sj.bjp.0704410","article-title":"Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina","volume":"134","author":"Utsunomiya","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.06.136_b0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2176\/nmc.48.241","article-title":"Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study","volume":"48","author":"Suzuki","year":"2008","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.bbrc.2012.06.136_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(01)01181-5","article-title":"Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats","volume":"427","author":"Ikegaki","year":"2001","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12012387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12012387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T08:37:23Z","timestamp":1743669443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12012387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0006291X12012387"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.06.136","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}